Leidos Holdings, Inc. (LDOS) SEC Filings & Earnings Calls
EquiReason read 17 Leidos Holdings, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-05 — Leidos formed a joint venture with Altaris (via AHP Entities) combining security screening businesses under Analogic brand. Leidos retains minority stake; JV governed by amended LL.
Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason
- Market cap
- 17.1B
- P/E TTM
- 12.7
- Dividend yield
- 1.2%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Oct 20268-K · 1.01, 7.01Leidos formed a joint venture with Altaris (via AHP Entities) combining security screening businesses under Analogic brand. Leidos retains minority stake; JV governed by amended LLC agreement with AHP majority board control.open
Figures in the filing · each found in the filing text
| annual_revenues · FY2026 | $17.20B |
Risks flagged
Integration risk; JV may not achieve expected synergies.
“Ability of the new joint venture company to successfully integrate the SES business and Analogic” · word for word
4 Aug 20268-K · 2.02Net income $356M (-9% y/y); Adjusted EBITDA $631M (-2% y/y); Non-GAAP Diluted EPS $3.26 (+2% y/y); Guidance: Full-year guidance raised for revenues, earnings, and cashearningsopen
Figures in the filing · each found in the filing text
| Net income · Q2-2026 | $356M | -9% y/y |
| Adjusted EBITDA · Q2-2026 | $631M | -2% y/y |
| Non-GAAP Diluted EPS · Q2-2026 | $3.26 | +2% y/y |
| Cash Flows from Operations · Q2-2026 | $793M | |
| Free Cash Flow · Q2-2026 | $761M | |
| Net bookings · Q2-2026 | $4.90B | |
| Backlog · Q2-2026 | $48.70B | +5% y/y |
Guidance
Full-year guidance raised for revenues, earnings, and cash
CEO cites strong portfolio and visibility to raise FY2026 guidance for revenues, earnings, and cash.
Risks flagged
Adjusted EBITDA margin compression due to one-time gains in prior year and acquisition costs.
“Adjusted EBITDA margin of 13.8% decreased from 15.2% in the second quarter of 2025. Profitability in the year-ago quarter benefited from several one-time, non-operational gains, including a $25 million insurance reimbursement for legal costs.” · word for word
4 Aug 202610-QLeidos reported mixed results: strong revenue growth and bookings, but declining operating margin and net income due to acquisition costs and contract mix.earningsopen
Figures in the filing · each found in the filing text
| Revenues · Q2-2026 | $4.56B | +7% y/y |
| Revenues · H1-2026 | $8.96B | +5% y/y |
| Operating income · Q2-2026 | $514M | -10% y/y |
| Net income · Q2-2026 | $356M | -9% y/y |
| Net income attributable to Leidos common stockholders · Q2-2026 | $354M | -9% y/y |
| Operating margin · Q2-2026 | 11.3% | |
| Backlog · Q2-2026 | $48.71B | +5% y/y |
| Net bookings · Q2-2026 | $4.90B | +26% y/y |
| Net bookings · H1-2026 | $8.20B | +37% y/y |
| Cash and cash equivalents · Q2-2026 | $748M |
Risks flagged
Government funding uncertainty
“it is increasingly expected that lawmakers will rely on a short-term continuing resolution (CR) to keep the government funded beyond the September 30, 2026 deadline.” · word for word
Margin pressure from acquisitions and amortization
“Operating margin 11.3% 13.4%” · word for word
Integration risk from Entrust acquisition
“The increase was partially offset by increased amortization, acquisition and restructuring expenses.” · word for word
5 May 20268-K · 2.02Revenue $4.40B (+4% y/y); Net income $335M (-8% y/y); Adjusted EBITDA $614M (+2% y/y); Guidance: Raised full-year guidance for revenue, earnings, and cashearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $4.40B | +4% y/y |
| Net income · Q1-2026 | $335M | -8% y/y |
| Adjusted EBITDA · Q1-2026 | $614M | +2% y/y |
| Non-GAAP Diluted EPS · Q1-2026 | $3.13 | +5% y/y |
| Cash Flows from Operations · Q1-2026 | $301M | |
| Backlog · Q1-2026 | $48.40B | +4% y/y |
| Bookings · Q1-2026 | $3.30B |
Guidance
Raised full-year guidance for revenue, earnings, and cash
Raised full-year guidance due to strong Q1 performance and confidence in multiyear growth acceleration.
Risks flagged
Acquisition-related costs impacted net income; $39M in costs for Entrust acquisition and joint venture.
“Net income and diluted EPS for the quarter reflect $39 million in costs associated with the acquisition of ENTRUST Solutions Group and the pending joint venture.” · word for word
5 May 202610-QRevenue $4.40B (+4% y/y); Net Income $335M (-8% y/y); Operating Cash Flow $301M (+419% y/y)open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $4.40B | +4% y/y |
| Net Income · Q1-2026 | $335M | -8% y/y |
| Operating Cash Flow · Q1-2026 | $301M | +419% y/y |
| Backlog · 2026-04-03 | $48.37B | +5% y/y |
| Bookings · Q1-2026 | $3.30B | +57% y/y |
Risks flagged
Segment margin deterioration in Homeland and Defense
“Homeland operating margin 4.0% vs 7.9%; Defense operating margin 7.0% vs 8.4%.”
Increased debt from acquisition
“Outstanding debt $6.3 billion vs $4.6 billion at year-end.”
15 Apr 20268-K · 1.01, 7.01Leidos contributed its Security Enterprise Solutions and Industrial Automation businesses to a new joint venture with Altaris portfolio company Analogic, receiving 41.5% equity; Altaris contributed Analogic and cash from new debt financingopen
Risks flagged
Transaction subject to regulatory approvals and debt financing; termination rights if not closed within six months (plus three-month extension).
“consummation of the Transactions is subject to the satisfaction or waiver of certain customary closing conditions, including (i) the expiration or termination of any applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act... (vi) the JV obtaining the Debt Financing.”
30 Mar 20268-K · 2.01, 7.01Acquisition consideration $2.40B; Employees added 3,100; Annual revenue (Leidos) $17.20Bacquisitionopen
Figures in the filing · each found in the filing text
| Acquisition consideration | $2.40B | |
| Employees added | 3,100 | |
| Annual revenue (Leidos) · FY2026 | $17.20B |
Risks flagged
Integration risk from large acquisition; $2.4B cash outlay may pressure balance sheet if not financed as planned.
“our ability to complete and integrate this transaction; our ability to complete the intended permanent financing” · word for word
19 Mar 2026DEF 14AProxy statement filed for 2026 annual meeting, including advisory vote on executive compensation and approval of the 2026 Omnibus Incentive Plan.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $17.17B | +3% y/y |
| Net Income Margin · FY2025 | 8.5% | |
| Adjusted EBITDA Margin · FY2025 | 14.1% | |
| Operating Cash Flow · FY2025 | $1.75B | +22% y/y |
| Net Bookings · FY2025 | $17.50B | |
| Total Shareholder Return (3-year) · 2023-2025 | 94.1% | |
| Adjusted EPS (PRSU hurdle) · FY2025 | $5.35 | |
| CEO Total Compensation · FY2025 | $15M | |
| Median Employee Compensation · FY2025 | $120427.00 | |
| Compensation Peer Group Revenue Percentile · FY2025 | 65.0% |
17 Feb 20268-K · 1.01, 2.03Leidos amended its credit agreement, increasing revolving commitments from $1B to $1.5B, extending maturity to 5 years, and reducing fees. No borrowings outstanding; facility for general corporate purposes.open
Figures in the filing · each found in the filing text
| Revolving credit facility commitments · 2026-02-12 | $1.50B |
Risks flagged
Increased leverage capacity but no borrowings outstanding; low risk.
“As of the Restatement Effective Date, no borrowings were outstanding under the revolving credit facility.” · word for word
17 Feb 20268-K · 2.02, 7.01Revenues $17.17B (+3% y/y); Net income $1.46B (+17% y/y); Diluted EPS $11.14 (+21% y/y); Guidance: FY2026 guidance: continued growth in revenues and non-GAAP diluted EPS, robust cash flows.earningsopen
Figures in the filing · each found in the filing text
| Revenues · FY2025 | $17.17B | +3% y/y |
| Net income · FY2025 | $1.46B | +17% y/y |
| Diluted EPS · FY2025 | $11.14 | +21% y/y |
| Non-GAAP Diluted EPS · FY2025 | $11.99 | +17% y/y |
| Adjusted EBITDA · FY2025 | $2.42B | +12% y/y |
| Free Cash Flow · FY2025 | $1.63B | +26% y/y |
| Net Bookings · FY2025 | $17.50B |
Guidance
FY2026 guidance: continued growth in revenues and non-GAAP diluted EPS, robust cash flows.
Management raised FY2026 guidance, forecasting continued revenue and EPS growth, robust cash flows, supported by strong bookings and margin expansion.
Risks flagged
Government shutdown impact on Q4 revenues (six-week shutdown).
“Revenues down 4% year-over-year primarily as a result of an extra work week in the fourth quarter of fiscal year 2024 and the six-week government shutdown in the fourth quarter of 2025.”
High debt level ($4.6B) relative to cash ($1.1B).
“As of January 2, 2026, the Company had $1.1 billion in cash and cash equivalents and $4.6 billion in debt.” · word for word
17 Feb 202610-KCompany-funded R&D $187M (+25% y/y); Employees 47,000open
Figures in the filing · each found in the filing text
| Company-funded R&D · FY2025 | $187M | +25% y/y |
| Employees · 2026-01-02 | 47,000 |
Risks flagged
U.S. Government Budget Dependency
“A decline in the U.S. government budget, changes in spending or budgetary priorities or delays in contract awards may significantly and adversely affect our future revenues and limit our growth prospects.” · word for word
Cybersecurity Breach Risk
“Cybersecurity breaches and other information security incidents could negatively impact our business and financial results.” · word for word
Competitive Bidding and Bid Protest Risk
“Due to the competitive process to obtain contracts and the likelihood of bid protests, we may be unable to achieve or sustain revenue growth and profitability.” · word for word
26 Jan 20268-K · 1.01, 7.01Leidos subsidiary agreed to acquire Entrust for $2.4B cash, expected close Q2 2026. Acquisition strengthens energy infrastructure growth pillar.acquisitionopen
Risks flagged
Integration risk and regulatory approval required; HSR waiting period.
“subject to the satisfaction or waiver of certain customary closing conditions, including ... the expiration or termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act” · word for word
4 Nov 202510-QLeidos reported Q3 2025 revenue of $4.469B (+6.7% YoY) and net income of $369M (+1.9% YoY), with backlog up 4.7% and a significant tax benefit from OBBBA.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $4.47B | +7% y/y |
| Net income · Q3-2025 | $369M | +2% y/y |
| Operating cash flow · Q3-2025 | $711M | +10% y/y |
| Backlog · 2025-10-03 | $47.66B | +5% y/y |
| Bookings · Q3-2025 | $5.90B | -26% y/y |
Risks flagged
Government shutdown risk
“On October 1, 2025, the federal government shutdown following the expiration of a continuing resolution.” · word for word
Interest expense increase
“Non-operating expense increased due to $1B senior notes issued in February 2025.”
4 Nov 20258-K · 2.02Revenues $4.47B (+7% y/y); Net income $369M (+2% y/y); Adjusted EBITDA $616M (+3% y/y); Guidance: Raising 2025 earnings and margin guidanceearningsopen
Figures in the filing · each found in the filing text
| Revenues · Q3-2025 | $4.47B | +7% y/y |
| Net income · Q3-2025 | $369M | +2% y/y |
| Adjusted EBITDA · Q3-2025 | $616M | +3% y/y |
| Non-GAAP Diluted Earnings per Share · Q3-2025 | $3.05 | +4% y/y |
| Cash Flows from Operations · Q3-2025 | $711M | |
| Non-GAAP Free Cash Flow · Q3-2025 | $680M | |
| Net bookings · Q3-2025 | $5.90B | |
| Backlog · Q3-2025 | $47.70B | +5% y/y |
| Diluted earnings per share · Q3-2025 | $2.82 | +5% y/y |
Guidance
Raising 2025 earnings and margin guidance
Raising full-year earnings and margin guidance; holding revenue and cash guidance; strong demand and backlog
Risks flagged
Legal reserve increase of $24 million; government shutdown impact
“Profitability remained high despite a $24 million increase to legal reserves” · word for word
Government contract awards
federal awards · contract value, often multi-year| Date | Agency | Value | What for |
|---|---|---|---|
| 2026-09-30 | National Institutes of Health | $342M | NCI OPERATIONAL TASK ORDER, FY26-FY27 |
| 2026-09-30 | Federal Acquisition Service | $15M | FUNDING MOD |
| 2026-09-30 | U.S. Immigration and Customs Enforcement | $15M | IMMIGRATION & CUSTOMS ENFORCEMENT(ICE) ELECTRONIC HEALTH RECORDS BLANKET PURCHASE AGREEMENT(BPA) CALL #1 TO BUILD AN ELECTRONIC HEALTH RECORDS SYSTEM TO BE USED BY ICE FOR HEALTH R |
| 2026-09-29 | Social Security Administration | $242M | THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION YEAR 5, ADD AN OPTION YEAR 5 TRAVEL CLIN, ADD AN OPTION YEAR 5 FFP CLIN, ADD THREE NEW REQUIREMENTS, AND UPDATE THE PRICING T |
| 2026-09-29 | National Institutes of Health | $72M | FUNCTIONAL PRECISION MEDICINE AND RESPONSE ASSAYS |
| 2026-09-29 | Federal Acquisition Service | $33M | CEILING INCREASE, ROLLOVER OY2 FUNDING, PROVIDE FUNDING FOR OY3 & NS |
| 2026-09-29 | Federal Acquisition Service | $20M | THE PURPOSE OF THIS MODIFICATION IS TO INCREMENTALLY FUND OY4 CLINS, DE-OBLIGATE FUNDS FROM OY2 AND OY3 CLINS AND RE-OBLIGATE THEM TO OY4 CLINS, REALIGN FUNDING IN OY3 AND OY4 CLI |
| 2026-09-28 | Bureau of Alcohol, Tobacco, Firearms and | $10M | ESA V MANAGED SERVICES (ATF AND FCS) |
| 2026-09-28 | Federal Law Enforcement Training Center | $9M | STUDENT ADMINISTRATION AND SCHEDULING SYSTEM (SASS) PROJECT MANAGEMENT. |
| 2026-09-25 | National Institutes of Health | $60M | NIAID DCR FY26-27 OPERATIONAL TASK ORDER |
Leidos Holdings, Inc. — questions
- What did Leidos Holdings, Inc. file recently?
- 17 SEC filings in the last 12 months. Latest: 8-K on 2026-10-05 — Leidos formed a joint venture with Altaris (via AHP Entities) combining security screening businesses under Analogic brand. Leidos retains minority stake; JV governed by amended LLC agreement with AHP majority board control.
Every figure on this page comes from Leidos Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.